Skip to main content

Table 3 Characteristics of patients aged 75 and over who were administered at least two psychotropic drugs and one long-half-life benzodiazepine (cases, N = 349) compared to four control groups of patients aged 75 and over who were not administered such a prescription during their hospital stay; Bordeaux, from July 2014 to July 2015

From: Appropriateness of psychotropic drug prescriptions in the elderly: structuring tools based on data extracted from the hospital information system to understand physician practices

Characteristics

Cases (N=349)

Control group 1a (N=573)

Control group 2 b (N=5838)

Control group 3 c (N=1601)

Control group 4d (N=8282)

N

%

N

%

N

%

N

%

N

%

Gender

 Male

139

40.0

193

33.7

2514

43.1

763

47.7

3980

48.1

 Female

210

60.0

380

66.3

3324

56.9

838

52.3

4302

51.9

Stay with high level of severity

 Yes

245

70.2

383

66.8

2794

47.9

751

46.9

1770

21.4

 No

104

29.8

190

33.2

3044

52.1

850

53.1

6512

78.6

Primary diagnosis during staye

 Cognitive symptoms

42

12.0

41

7.2

131

2.2

40

2.5

104

1.3

 Vascular dementia

20

5.7

10

1.7

20

0.3

6

0.4

17

0.2

 Mood symptoms

18

5.2

4

0.7

14

0.2

8

0.5

5

0.1

Psychiatric disorderse

 Dementia

127

36.4

167

29.1

795

13.6

193

12.1

595

7.2

 Mood disorders

93

26.6

179

31.2

627

10.7

132

8.2

217

2.6

 Anxiety disorders

94

26.9

168

29.3

569

9.7

197

12.3

243

2.9

 Alcohol addiction

26

7.4

21

3.7

145

2.5

43

2.7

131

1.6

Dependence

137

39.3

213

37.2

1153

19.7

370

23.1

844

10.2

Social status

 Living alone at home

21

6.0

32

5.6

241

4.1

46

2.9

173

2.1

 Requiring nursing home entry

18

5.2

27

4.7

161

2.8

43

2.7

64

0.8

  1. aControl group 1: patients who were administered two psychotropic drugs without any long half-life benzodiazepine
  2. bControl group 2: patients who were administered one psychotropic drug without any long half-life benzodiazepine
  3. c Control group 3: patients who were administered at least one long half-life benzodiazepine without any psychotropic drugs
  4. d Control group 4: patients who were not administered any psychotropic drugs nor any long half-life benzodiazepine
  5. eCodes of the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10): Cognitive symptoms (R41); Vascular Dementia (F01); Mood symptoms (R45); Dementia (F00, F01, F02, F03); Mood disorders (F32, F33, F38, F39); Anxiety disorders (F40, F41, F42, F43); Alcohol addiction (F10)